ITOS

iTeos Therapeutics, Inc.

Insider trading activity for iTeos Therapeutics, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 32 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Aug 29, 2025	Rhoads Ann D	Director	DTOISS◆	27,178	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	McGrath Yvonne	Chief Scientific Officer	DTOISS◆	16,054	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	McGrath Yvonne	Chief Scientific Officer	DTOISS◆	69,069	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	McGrath Yvonne	Chief Scientific Officer	DTOISS◆	91,000	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	McGrath Yvonne	Chief Scientific Officer	UTENDR	46,300	—	—	-100.0%	Open the original filing on SEC.gov
Aug 29, 2025	Lee David K	Director	DTOISS◆	23,625	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Lee David K	Director	DTOISS◆	21,141	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Hallal David	Director	DTOISS◆	146,160	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Hallal David	Director	DTOISS◆	25,140	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Gall Matthew	Chief Financial Officer	DTOISS◆	252,135	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Gall Matthew	Chief Financial Officer	DTOISS◆	8,123	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Gall Matthew	Chief Financial Officer	DTOISS◆	42,388	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Gall Matthew	Chief Financial Officer	DTOISS◆	135,937	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Gall Matthew	Chief Financial Officer	DTOISS◆	9,063	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Gall Matthew	Chief Financial Officer	UTENDR	89,429	—	—	-100.0%	Open the original filing on SEC.gov
Aug 29, 2025	Feltquate David	Chief Medical Officer	UTENDR	47,000	—	—	-100.0%	Open the original filing on SEC.gov
Aug 29, 2025	Detheux Michel	Chief Executive Officer	DTOISS◆	52,700	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Detheux Michel	Chief Executive Officer	DTOISS◆	185,000	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Detheux Michel	Chief Executive Officer	DTOISS◆	17,544	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Detheux Michel	Chief Executive Officer	DTOISS◆	50,128	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Detheux Michel	Chief Executive Officer	DTOISS◆	94,336	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Detheux Michel	Chief Executive Officer	DTOISS◆	444,815	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Detheux Michel	Chief Executive Officer	DTOISS◆	14,185	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Detheux Michel	Chief Executive Officer	UTENDR	94,027	—	—	-100.0%	Open the original filing on SEC.gov
Aug 29, 2025	Detheux Michel	Chief Executive Officer	UTENDR	153,903	—	—	-100.0%	Open the original filing on SEC.gov
Aug 29, 2025	Call Matthew	Chief Operating Officer	DTOISS◆	146,835	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Call Matthew	Chief Operating Officer	DTOISS◆	17,074	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Call Matthew	Chief Operating Officer	DTOISS◆	66,170	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Call Matthew	Chief Operating Officer	DTOISS◆	41,694	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Call Matthew	Chief Operating Officer	DTOISS◆	135,937	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Call Matthew	Chief Operating Officer	DTOISS◆	9,063	—	—	—	Open the original filing on SEC.gov
Aug 29, 2025	Call Matthew	Chief Operating Officer	UTENDR	161,898	—	—	-100.0%	Open the original filing on SEC.gov

DTOISS◆—

Rhoads Ann D · DirectorAug 29, 2025

27,178 sh

DTOISS◆—

McGrath Yvonne · Chief Scientific…Aug 29, 2025

16,054 sh

DTOISS◆—

McGrath Yvonne · Chief Scientific…Aug 29, 2025

69,069 sh

DTOISS◆—

McGrath Yvonne · Chief Scientific…Aug 29, 2025

91,000 sh

UTENDR—

McGrath Yvonne · Chief Scientific…Aug 29, 2025

46,300 sh · -100.0% own

DTOISS◆—

Lee David K · DirectorAug 29, 2025

23,625 sh

DTOISS◆—

Lee David K · DirectorAug 29, 2025

21,141 sh

DTOISS◆—

Hallal David · DirectorAug 29, 2025

146,160 sh

DTOISS◆—

Hallal David · DirectorAug 29, 2025

25,140 sh

DTOISS◆—

Gall Matthew · Chief Financial…Aug 29, 2025

252,135 sh

DTOISS◆—

Gall Matthew · Chief Financial…Aug 29, 2025

8,123 sh

DTOISS◆—

Gall Matthew · Chief Financial…Aug 29, 2025

42,388 sh

DTOISS◆—

Gall Matthew · Chief Financial…Aug 29, 2025

135,937 sh

DTOISS◆—

Gall Matthew · Chief Financial…Aug 29, 2025

9,063 sh

UTENDR—

Gall Matthew · Chief Financial…Aug 29, 2025

89,429 sh · -100.0% own

UTENDR—

Feltquate David · Chief Medical…Aug 29, 2025

47,000 sh · -100.0% own

DTOISS◆—